title: [Patients with calcinosis cutis in National Leprosarium Matsuoka Hoyo-En].
abstract: As of the year 1991 there were 358 leprosy patients in National Leprosarium Matsuoka Hoyo-En, including 223 patients (62.3%) who had received the injections of chaulmoogra oil before. Calcinosis cutis caused probably from the injections was noted on 73 patients (32.7%): 67 lepromatous and 6 tuberculosis cases. It has never been reported before that the T type patient suffering from calcinosis cutis was observed in the cases of the chaulmoogra oil injection in Japan. The detectable positions of calcinosis cutis were mostly at the injected sites, that is, outside the right brachium followed by bilateral-branchia and crura. In the group of patients with calcinosis cutis, the anti-PGL antibody was negative for the most part. Urinalyses, peripheral blood figure analyses, histopathological tissue examinations of calcium deposition, X-ray diffraction patterns, differential thermal and gravitational analyses, and chemical analyses were performed on all patients with this disease. Further, as the result of this study six patients with calcinosis cutis caused by sulpyrine was also found. The major component of the deposit by the drug was calcium phosphate. These calcinosis cutis were considered to be of trophopathic calcinosis based on the disorder of subcutaneous tissue due to the injections of respective drugs: chaulmoogra oil and sulpyrine.
authors: National Leprosarium Matsuoka Hoyo-En, Aomori, Japan.
authors: K
authors: K
authors: Ohtaka
mesh_terms: D002114:Calcinosis / Q000209:etiology* / Q000378:metabolism / Q000473:pathology; D002130:Calcium Phosphates / Q000378:metabolism; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous / Q000009:adverse effects; D007564:Japan; D007914:Leper Colonies; D007917:Leprostatic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D007918:Leprosy / Q000150:complications*; D008297:Male; D010938:Plant Oils / Q000008:administration & dosage / Q000009:adverse effects*; D012871:Skin Diseases / Q000209:etiology* / Q000378:metabolism / Q000473:pathology
chemical_list: D002130:Calcium Phosphates; D007917:Leprostatic Agents; D010938:Plant Oils; C100206:chaulmoogra oil